Degron Therapeutics vs Neoflow Technologies
Degron Therapeutics vs Neoflow Technologies, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Degron Therapeutics is on 62/100 and Neoflow Technologies on 47/100.
Where each one leads
Degron Therapeutics
- our overall score: 62/100 against 47/100
- funding raised: $40.0M against $10.0M
Neoflow Technologies
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Degron Therapeutics | Neoflow Technologies |
|---|---|---|
| What it is | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. | Develops an endovascular solution for vasospasm treatment in aneurysmal subarachnoid hemorrhage. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare | Healthcare, Medical Device, MedTech, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Hardware |
| Founded | 2020 | 2022 |
| Headquarters | San Diego, USA | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Degron Therapeutics | Neoflow Technologies |
|---|---|---|
| Employees | 24 | Not published |
| Total funding | $40.0M | $10.0M |
| Latest round | Series A Extension | Seed |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 1,380 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Degron Therapeutics | Neoflow Technologies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 47/100 |
| Traction | Not published | 11/100 |
| Team | 24/100 | Not published |
| Search visibility | 57/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (27/100) | Not published |
| Domain ratingLink authority, 0-100 | 25/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Degron Therapeutics | Neoflow Technologies |
|---|---|---|
| Hosting | Self Managed | Not detected |
Degron Therapeutics vs Neoflow Technologies: common questions
Which is better, Degron Therapeutics or Neoflow Technologies?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.
How do Degron Therapeutics and Neoflow Technologies compare on the numbers?
Degron Therapeutics leads on our overall score (62/100 against 47/100), funding raised ($40.0M against $10.0M).
Read the full Degron Therapeutics review and pricing or the Neoflow Technologies review and pricing. You can also browse other Degron Therapeutics alternatives we track.